Hypoxia plays a critical role in the metastasis of gastric cancer (GC), yet the underlying mechanism remains largely unclear. It is also not known whether long, noncoding RNAs (lncRNAs) are involved in the contribution of hypoxia to GC metastasis. In the present study, we found that lncRNA BC005927 can be induced by hypoxia in GC cells and mediates hypoxia-induced GC cell metastasis. Furthermore, BC005927 is frequently upregulated in GC samples and increased BC005927 expression was correlated with a higher tumor-node-metastasis stage. GC patients with higher BC005927 expression had poorer prognoses than those with lower expression. Additional experiments showed that BC005927 expression is induced by hypoxia inducible factor-1 alpha (HIF-1a); ChIP assay and luciferase reporter assays confirmed that this lncRNA is a direct transcriptional target of HIF-1a. Next, we found that EPHB4, a metastasis-related gene, is regulated by BC005927 and that the expression of EPHB4 was positively correlated with that of BC005927 in the clinical GC samples assessed. Intriguingly, EPHB4 expression was also increased under hypoxia, and its upregulation by BC005927 resulted in hypoxia-induced GC cell metastasis. These results advance the current understanding of the role of BC005927 in the regulation of hypoxia signaling and offer new avenues for the development of therapeutic interventions against cancer progression.
| INTRODUCTION
Gastric cancer (GC) is one of the most common human cancers: it is the third most common human cancer in the world, and the second most common cancer in China. 1 Despite recent advances in clinical and experimental oncology, the prognosis of GC remains poor, with the 5-year survival rate of patients with this type of cancer remaining relatively low. 2 As the major cause of death is metastasis, which greatly hinders treatment success, 3 better understanding of the mechanisms underlying GC metastasis is crucial for improving the diagnosis and treatment of GC patients. A hypoxic microenvironment plays a critical role in the metastasis and recurrence of certain cancer types, including GC, hepatocellular carcinoma (HCC) and colorectal cancer. [4] [5] [6] [7] [8] [9] Indeed, it is well established that hypoxia contributes to metastasis by regulating the expression of various protein-coding genes, 10, 11 and our previous study also found that hypoxia could prompt gastric cancer metastasis and hypoxia inducible factor-1 (HIF-1) was involved in this process 12, 13 Further study explored that HIF-1 regulated protein-coding genes by binding to hypoxia response elements (HRE) in gene promoters in hypoxic GC. 14 However, only 2% of the human transcriptome is composed of protein-coding mRNAs; most of the transcriptome comprises noncoding transcripts that yield long, noncoding RNAs (lncRNAs), which are defined as transcripts longer than 200 nucleotides (nt). [15] [16] [17] Thus far, more than 10 000 lncRNAs have been reported as playing crucial roles in diverse cancer processes by various mechanisms, such as chromatin remodeling 18, 19 and transcriptional regulation, in addition to aiding in the repair of DNA damage. 20, 21 Although a number of lncRNAs have been reported to play critical roles in diverse processes, only a few examples of lncRNA-mediated transcriptional regulation in hypoxia-related cancer have been described. For example, Yang et al 22 have shown that a hypoxic microenvironment suppresses lncRNA low expression in tumor (lncRNA-LET), which is associated with HCC metastasis. In another study, Fan Yang et al 23 found that lincRNA-p21 is a hypoxia-responsive lncRNA that is essential for hypoxia-enhanced glycolysis. Therefore, an understanding of the roles and specific regulatory mechanisms of lncRNAs in hypoxia-induced GC metastasis is urgently needed.
Using microarrays, we previously identified a small number of lncRNAs that are aberrantly expressed in GC under hypoxia compared with normoxia. 24 In the present study, we describe our further analysis of one such lncRNA, BC005927, an 817-bp, unspliced, polyadenylated transcript transcribed from the intron of the SER-PINE1 gene on chromosome 7 that is upregulated by hypoxia, showing increased expression in hypoxia-induced GC cells and GC tissues.
We found that BC005927 promotes GC metastasis, whereas downregulation of BC005927 inhibits GC invasion in vitro and in vivo under hypoxic conditions. We further show that BC005927 is a direct transcriptional target of HIF-1a through the interaction of its promoter region with a putative HIF-1a response element. Moreover, we show that alteration of BC005927 expression influences the expression of EPHB4, which is located 300 kb upstream of BC005927, indicating that BC005927 affects GC cell invasion and metastasis partially through EPHB4. This study advances the current understanding of the roles of lncRNAs, which include regulation of the pathogenesis of hypoxia-related GC, thus facilitating the development of lncRNA-directed diagnostics and therapeutics. 
| Clinical samples
Samples from 95 GC patients who had undergone gastrectomy with lymph node dissection for GC at Xijing Hospital between November 2007 and April 2009 were included in the present study (Table S2) .
None of the patients received preoperative chemotherapy. The resected specimens were histologically examined by hematoxylineosin (HE) staining. Primary tumor samples and corresponding nontumor mucosa were collected from each patient immediately after the surgical process and were snap-frozen in liquid nitrogen until further use. Total RNA from the frozen tissues was isolated with TRIzol (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions.
| Western blotting
Cellular proteins were extracted using lysis buffer at 4°C on ice.
Lysates were centrifuged at 9500 g for 10 minutes at 4°C, and the supernatants were collected. Western blotting was then done according to standard procedures. 25 Rabbit anti-EPHB4 monoclonal antibody used was obtained from Abcam (Cambridge, MA, USA) and mouse anti-b-actin monoclonal antibody from Sigma-Aldrich (St Louis, MO, USA). Bands were detected using an ECL system (Santa Cruz Biotechnology, Santa Cruz, CA, USA), and b-actin expression was used as an internal control.
| Construct design and cell transfection
On the basis of the BC005927 sequence, 4 shRNAs were designed using small interfering RNA Target 
| Luciferase assay
To investigate whether BC005927 is transcriptionally regulated by HIF-1a, SGC7901 cells expressing either control shRNA or HIF-1a
shRNA were transfected with a pGL3-based construct containing the BC005927 promoter plus a Renilla luciferase plasmid. Twenty-four hours later, the cells were cultured under normoxic or hypoxic conditions for another 24 hours. Reporter activity was measured using a luciferase assay kit (Promega, Madison, WI, USA) and plotted after normalization with respect to Renilla luciferase activity (mean AE SD).
| Bisulfite sequencing PCR analyses
Genomic DNA was extracted from GC cells with the QIAamp DNA Mini Kit (Qiagen, Germantown, MD, USA) and subjected to bisulfite modification using an EpiTect â Bisulfite kit (Qiagen) according to the manufacturer's protocol. PCR was carried out and the PCR product was ligated into T Vector. After transformation, individual colonies were selected, and the insert was sequenced and analyzed by BiQ_Analyzer.
| Statistical analysis
The SPSS 12.0 program (SPSS Inc., Chicago, IL, USA) was used for statistical analysis. Data are presented as mean AE standard error for at least 3 independent experiments. Differences between groups were analyzed using Student's t test when comparing only 2 groups or a one-way analysis of variance when comparing more than 2 groups.
The chi-squared test was used to analyze the relationships between EPHB4 expression and various clinicopathological characteristics.
BC005927 and EPHB4 expression levels in clinical GC tissues and corresponding adjacent non-tumorous tissues were compared using Wilcoxon signed-rank test, and correlations between BC005927 and EPHB4 expression in the tissue specimens were explored using Pearson's correlation. P < .05 was considered statistically significant.
3 | RESULTS
| Aberrant expression of BC005927 lncRNA in hypoxia-induced GC cells and GC tissues
In our previous study, we found that lncRNA BC005927, which is an 817-bp, exon sense-overlapping lncRNA on chromosome 7, was upregulated by hypoxia comparing hypoxia-induced GC to normoxia conditions using microarrays. 24 Bioinformatics analysis showed pro- Figure 1A1 , A2, A3). These data indicate the specificity of BC005927 in hypoxic induction. The results suggest that BC005927 can, indeed, be regulated by hypoxia in GC cells.
To further study BC005927 expression in tumor tissues in vivo,
we examined a panel of paired tumor and normal primary tissue specimens that were collected from patients with GC (n = 95).
BC005927 transcripts were found to be expressed at higher levels , lncRNA-BC005927 expression was assessed by real-time PCR in 95 pairs of human GC and adjacent tissues. b-Actin was used as an internal control. Significant differences between samples were analyzed using the Wilcoxon signed-rank test (P = .002, n = 95). (D) Kaplan -Meier's analysis of the correlation between BC005927 expression and overall survival (OS) of GC patients. In all panels, results are representative of at least 3 independent experiments *P < .05, **P < .01 node metastasis (P = .0032). BC005927 expression in GC patients was not found to be correlated with age, gender, tumor size or cell differentiation (data not shown). Moreover, we examined whether the level of BC005927 expression was associated with survival in GC patients. Patients were subsequently divided into high expression (n = 48) and low expression groups (n = 47) based on BC005927 expression levels greater (equal) or less than the median expression (5.676). Kaplan-Meier survival analyses showed that patients with high BC005927 expression had a shorter survival time than those with low BC005927 expression ( Figure 1D ). Therefore, the high expression of this lncRNA might be associated with GC metastasis.
| BC005927 is induced by HIF-1a, and HIF-1a
interacts with the HIF-1a response element in the BC005927 promoter region Next, ChIP assays verified the association of HIF-1a and the chromatin fragments corresponding to the two HRE within the BC005927 gene ( Figure 2E ). In addition, we used the HRE-luciferase reporter system to examine how lnc affects HIF-1-regulated luciferase expression. DNA fragments containing wild-type or mutant HRE were inserted into the promoter region of a firefly luciferase reporter plasmid. As expected, luciferase expression from the wild type, but not the mutant reporter, was markedly induced by hypoxia (Figure 2F1, F2 ). This hypoxia-induced luciferase expression, however, was greatly inhibited by knockdown of HIF-1a ( Figure 2G1, G2 ).
These data show that BC005927 is transcriptionally upregulated by HIF-1a. Given the intronic position of BC005927 within SERPINE1, we next aimed to determine the effect of BC005927 knockdown/upregulation on SERPINE1 expression in GC cells. As a result, we found that the level of SERPINE1 expression was not significantly altered following BC005927 knockdown or following overexpression of BC005927 relative to the negative control ( Figure S1 ). This result confirms that the knockdown/knockup strategy did not appreciably affect the levels of the host SERPINE1 transcript and that the phenotypic effects observed following knockdown/knockup of BC005927 were driven directly by BC005927.
We then determined whether BC005927 could affect normoxic 
| Association of BC005927 with EPHB4
To explore the mechanism by which BC005927 promotes GC cell migration and invasion, we attempted to identify the potential target genes of lncRNA. Recently, several studies have found that many lncRNAs are involved in molecular regulation pathways through interactions with neighboring proteins. Thus, we sought to identify proteins associated with this lncRNA using a bioinformatics analysis.
We retrieved genomic locus information from the UCSC genome browser (http://genome.ucsc.edu/) and found that the tumor oncogene EPHB4, a metastasis-associated gene, is located 300 kb F I G U R E 2 BC005927 is induced by hypoxia inducible factor-1 alpha (HIF-1a), and HIF-1a interacts with the HIF-1a response element in the BC005927 promoter region. A, Schematic illustration of consensus HIF-1a response element in BC005927 gene promoter. B, C1, C2, SGC7901, MKN45 cells expressing control shRNA, HIF-1a shRNAs were cultured under hypoxic conditions for 24 hours. Cell lysates and total RNA were subjected to western blot and real-time RT-PCR analyses, respectively. Data shown are mean AE SD (n = 3). D1, D2, Cell lysates and total RNA of MKN28 cells expressing NC (negative control) or pc-DNA-HIF-1a were subjected to western blot and real-time RT-PCR analyses, respectively. Data shown are mean AE SD (n = 3). E, SGC7901 cells were cultured under normoxic or hypoxic conditions for 24 hours. Lysates were then subjected to ChIP assay. ChIP products were amplified by PCR reaction. F1, F2, SGC7901 cells were cotransfected with the indicated reporter constructs and Renilla luciferase plasmid. Twenty-four hours after transfection, cells were cultured under normoxic or hypoxic conditions for 24 hours. Reporter activity was then measured and plotted after normalizing with respect to Renilla luciferase activity (mean AE SD). G1, G2, SGC7901 cells expressing control shRNA, HIF-1a-si1, or HIF-1a-si2 were cotransfected with the hypoxia response element (HRE)-WT reporter constructs and Renilla luciferase plasmid. Twenty-four hours after transfection, cells were cultured under normoxic or hypoxic conditions for 24 hours. Reporter activity was then measured and plotted after normalizing with respect to Renilla luciferase activity (mean AE SD). In all panels, results are representative of at least 3 independent experiments. **P < .01 LIU ET AL. Moreover, we found that the expression of EPHB4 was positively correlated with BC005927 expression in GC tissues (Figure 5D) . Immunohistochemistry results showed strong staining of EPHB4 at primary sites in the samples obtained from patients with metastatic GC compared with those from patients with nonmetastatic GC ( Figure 5E ). In addition, increased EPHB4 expression in the GC tissues was significantly correlated with TNM stage and lymph node metastasis, but was not associated with other parameters, such as gender, age or GC cell differentiation (Table S3 ). Next, to investigate the potential mechanism by which BC005927 induces the expression of EPHB4 in GC cells, we focused on DNA methylation of EPHB4, because lncRNAs are known to be involved in epigenetic regulation. Then, we carried out bisulfite sequencing of cloned alleles over the region of À145 to +34 of the EPHB4 promoter encompassing 18 CpG sites. 26 Results showed that EPHB4 CpG islands were densely hypomethylated in control SGC7901-si-Scr and MKN45-si-Scr cells, but GC cells transduced with BC005927 siRNA showed more methylated CpG dinucleotides ( Figure 5F ).
Taken together, these results show that knockdown of BC005927 can downregulate the expression of EPHB4 in GC cells by regulating EPHB4 DNA methylation, which illustrates that EPHB4 may act as a downstream target of BC005927 in GC cells.
| Upregulation of EPHB4 by BC005927 mediates hypoxia-induced GC metastasis
To determine whether EPHB4 is involved in BC005927-induced GC cell metastasis under hypoxia upregulated by lncRNA BC005927
in vitro, we measured its expression levels in BC005927-downregulated GC cells compared with control cells under hypoxia.
Western blot results showed that EPHB4 expression increased under hypoxia compared with normoxia. This increasing trend was abro- 
| DISCUSSION
It has been well established that hypoxia contributes to GC metastasis and invasion by regulating the expression of various protein-coding genes. 12, 13 However, approximately 97%-98% of transcriptional gene products do not encode proteins; these ncRNAs have biological functions in cancer development, fetal development, and cell growth. 27, 28 Of all the studied non-coding genes, lncRNAs have been garnering increasing interest. Recently, several studies have indicated functional roles of lncRNAs in tumorigenesis. [29] [30] [31] [32] [33] However, hypoxic lncRNAs are still an emerging research topic, and only a handful of lncRNAs are known to be involved in the development of disease under hypoxia. For example, Yang et al 22 showed that a hypoxic microenvironment suppresses lncRNA-LET, which is associated with HCC metastasis. In another study, Yang et al 23 found that lincRNAp21 is a hypoxia-responsive lncRNA that is essential for hypoxiaenhanced glycolysis. However, whether lncRNA is also involved in hypoxic GC has remained unknown to date.
In a previous study, we carried out a microarray analysis and identified a small number of lncRNAs that are aberrantly expressed in human hypoxia-related GC cells compared to normoxia-related GC cells. 24 In this study, among the upregulated lncRNAs, we found that lncRNA BC005927, an 817-bp, unspliced, polyadenylated transcript 51, 52 Overexpression of EPHB4 in the mammary epithelium of MMTV-neuT transgenic mice accelerated the onset of tumor formation and increased metastasis to the lungs. 53 In xenograft models of breast and prostate cancer, knockdown of EPHB4 significantly inhibits tumor growth indicating that EPHB4 directly contributes to tumor progression. 42, 43 Similarly, targeting EPHB4 using a monoclonal antibody also significantly reduced tumor growth in vivo. 39 EPHB4 overexpression also plays an important role in gastric carcinogenesis in Chinese patients. However, the specific function of EPHB4 in gastric carcinogenesis requires further study to be completely understood. 54 In our study, we found that EPHB4 was highly expressed at primary sites in patients with metastatic GC compared to those with nonmetastatic GC; increased EPHB4 expression in GC tissues was also significantly correlated with TNM stage and lymph node metastasis. Further experiments showed that knockdown of EPHB4 inhibited GC cell metastasis and invasion, whereas its upregulation impaired cell metastasis and invasion. These results indicate that the EPHB4 gene is a metastasis-associated gene in GC.
Moreover, we found that expression of EPHB4 is positively correlated with BC005927 expression in GC tissues. Accordingly, we Recently, increasing evidence confirmed that lncRNA can regulate DNA methylation of protein-coding genes during the development of disease, [55] [56] [57] [58] and several studies reported that EPHB4 expression is activated by demethylation of the EPHB4 CpG island in the development of a variety of cancers. 59 Interestingly, using BSP assays, we observed a robust increase in levels of DNA methylation of EPHB4 following depletion of BC005927.
Expression of EPHB4 was significantly increased in hypoxic GC cells and tissues, which was at least partially mediated by BC005927, suggesting that its upregulation may be a key factor for the development of GC and may indicate a higher risk of metastasis.
We show here that BC005927 possibly regulates the invasive and metastatic abilities of GC cells under hypoxia, partially through its regulation of EPHB4. Further studies are needed to investigate the exact mechanism of EPHB4 DNA demethylation that is induced by BC005927. Our findings further the understanding of GC pathogenesis and will facilitate the development of lncRNA-directed diagnostics and therapeutics for the treatment of cancer.
ACKNOWLEDG MENTS
The authors would like to thank Xijing Hospital (Xi'an, China) for specimens. The study was funded by National Natural Science F I G U R E 7 Upregulation of EPHB4 by BC005927 mediates hypoxia-induced gastric cancer (GC) metastasis. A1, A2, Protein levels of EPHB4 in SGC7901 and MKN45 cells. The cells were transfected with a BC005927 siRNA-lentivirus or negative control (NC) and then exposed to hypoxia after transfection. The cells were then collected and subjected to western blot analysis at specific time points, as indicated. 
CONF LICTS OF INTEREST
Authors declare no conflicts of interest for this article.
O R C I D
Lili Liu http://orcid.org/0000-0002-6035-3583
